Dexmedetomidine
2022-761
Approved small_molecule completed
Quick answer
Dexmedetomidine for Breast Cancer is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Breast Cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed